Literature DB >> 10690166

Prostate cancer prevention: review of target populations, pathological biomarkers, and chemopreventive agents.

R Montironi1, R Mazzucchelli, J R Marshall, P H Bartels.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10690166      PMCID： PMC501588          DOI： 10.1136/jcp.52.11.793

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN： 0021-9746            Impact factor:   3.411


× No keyword cloud information.
  75 in total

1.  Morphonuclear relationship between prostatic intraepithelial neoplasia and cancers as assessed by digital cell image analysis.

Authors:  M Petein; P Michel; R van Velthoven; J L Pasteels; M K Brawer; J R Davis; R B Nagle; R Kiss
Journal:  Am J Clin Pathol       Date:  1991-11       Impact factor: 2.493

2.  Genistein, a dietary-derived inhibitor of in vitro angiogenesis.

Authors:  T Fotsis; M Pepper; H Adlercreutz; G Fleischmann; T Hase; R Montesano; L Schweigerer
Journal:  Proc Natl Acad Sci U S A       Date:  1993-04-01       Impact factor: 11.205

3.  Significance of high-grade prostatic intraepithelial neoplasia on needle biopsy.

Authors:  M H Weinstein; J I Epstein
Journal:  Hum Pathol       Date:  1993-06       Impact factor: 3.466

Review 4.  Chemoprevention strategies for prostate cancer: the role of 5 alpha-reductase inhibitors.

Authors:  G J Gormley
Journal:  J Cell Biochem Suppl       Date:  1992

5.  Expression of sulfated glycoprotein 2 is associated with carcinogenesis induced by N-nitroso-N-methylurea in rat prostate and seminal vesicle.

Authors:  K Kadomatsu; M A Anzano; M V Slayter; T S Winokur; J M Smith; M B Sporn
Journal:  Cancer Res       Date:  1993-04-01       Impact factor: 12.701

6.  Randomized phase I chemoprevention dose-seeking study of alpha-difluoromethylornithine.

Authors:  R R Love; P P Carbone; A K Verma; D Gilmore; P Carey; K D Tutsch; M Pomplun; G Wilding
Journal:  J Natl Cancer Inst       Date:  1993-05-05       Impact factor: 13.506

7.  5-alpha-reductase activity and risk of prostate cancer among Japanese and US white and black males.

Authors:  R K Ross; L Bernstein; R A Lobo; H Shimizu; F Z Stanczyk; M C Pike; B E Henderson
Journal:  Lancet       Date:  1992-04-11       Impact factor: 79.321

Review 8.  The Lobund-Wistar rat model of prostate cancer.

Authors:  M Pollard
Journal:  J Cell Biochem Suppl       Date:  1992

Review 9.  Chemoprevention in prostate cancer: the role of difluoromethylornithine (DFMO).

Authors:  D Kadmon
Journal:  J Cell Biochem Suppl       Date:  1992

10.  Treatment of prostate cancer in the rat with the synthetic retinoid fenretinide.

Authors:  K J Pienta; N M Nguyen; J E Lehr
Journal:  Cancer Res       Date:  1993-01-15       Impact factor: 12.701
View more
  8 in total

1.  Prognostic factors in prostate cancer.

Authors:  R Montironi
Journal:  BMJ       Date:  2001-02-17

2.  The potential for prostate cancer chemoprevention.

Authors:  Otis W Brawley
Journal:  Rev Urol       Date:  2002

Review 3.  Morphological identification of the patterns of prostatic intraepithelial neoplasia and their importance.

Authors:  R Montironi; R Mazzucchelli; F Algaba; A Lopez-Beltran
Journal:  J Clin Pathol       Date:  2000-09       Impact factor: 3.411

4.  Tissue-based assay for ornithine decarboxylase to identify patients likely to respond to difluoromethylornithine.

Authors:  Victor A Levin; Jacob L Jochec; Lisa M Shantz; Patricia E Koch; Anthony E Pegg
Journal:  J Histochem Cytochem       Date:  2004-11       Impact factor: 2.479

Review 5.  Immunopathological prognostic and predictive factors in prostate cancer.

Authors:  E Sivridis; S Touloupidis; A Giatromanolaki
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 6.  [A critical assessment of phytotherapy for prostate cancer].

Authors:  F G E Perabo; E C von Löw; R Siener; J Ellinger; S C Müller; P J Bastian
Journal:  Urologe A       Date:  2009-03       Impact factor: 0.639

7.  EPMA position paper in cancer: current overview and future perspectives.

Authors:  Godfrey Grech; Xianquan Zhan; Byong Chul Yoo; Rostyslav Bubnov; Suzanne Hagan; Romano Danesi; Giorgio Vittadini; Dominic M Desiderio
Journal:  EPMA J       Date:  2015-04-15       Impact factor: 6.543

8.  Prostate cancer: a presentation of clinicopathologic prognosticators among Filipino and American men at radical prostatectomy.

Authors:  Mayen T Grageda; Bonnie Choy; Gladell P Paner; Jeffrey S So
Journal:  Asian J Androl       Date:  2021 Sep-Oct       Impact factor: 3.285
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.